CD4 and neoplasm: We previously reported that CD4+ TICs was found to be a significant and independent prognostic factor for favorable OS and to correlate with longer TFI [20], implicating that CD4+ helper T cells may affect patient prognosis through involvement in tumor chemosensitivity.